Aislinn Williams, MD/PhD

Psychiatry

Beverly L. Davidson	grad student	2010	University of Iowa
(Toxic intermediates and protein quality control in the polyglutamine disease, SCA3.)

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Williams AJ, Knutson TM, Colomer Gould VF, et al. (2009) In vivo suppression of polyglutamine neurotoxicity by C-terminus of Hsp70-interacting protein (CHIP) supports an aggregation model of pathogenesis. Neurobiology of Disease. 33: 342-53
Williams AJ, Paulson HL. (2008) Polyglutamine neurodegeneration: protein misfolding revisited. Trends in Neurosciences. 31: 521-8
Miller VM, Nelson RF, Gouvion CM, et al. (2005) CHIP suppresses polyglutamine aggregation and toxicity in vitro and in vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 9152-61
Chai Y, Shao J, Miller VM, et al. (2002) Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis. Proceedings of the National Academy of Sciences of the United States of America. 99: 9310-5